ArticleFrontiers in cardiovascular medicine2026
Red blood cell distribution width-to-albumin ratio and in-hospital major adverse cardiovascular events in patients with acute myocardial infarction complicated by cardiogenic shock: a two-center retrospective cohort study.
Article in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To investigate the relationship between red blood cell distribution width-to-albumin ratio (RAR) and major adverse cardiovascular events (MACE) in patients with acute myocardial infarction complicated by cardiogenic shock (AMI-CS) during hospitalization. Methods: This retrospective cohort study enrolled patients from Xuzhou Central Hospital and the First People's Hospital of Yancheng between January 2019 and December 2024. Patients were stratified into four quartiles according to admission RAR. The relationship between RAR and in-hospital MACE (all-cause death, recurrent non-fatal myocardial infarction, unplanned revascularization, non-fatal stroke) was assessed using multivariate logistic regression, Kaplan-Meier curves, and receiver operating characteristic (ROC) analysis. Results: A total of 3,316 AMI patients were screened and 264 AMI-CS patients were enrolled in this study. Mortality rates across RAR quartiles (lowest to highest) were 33.3%, 37.9%, 54.5%, and 66.7%, and MACE rates were 54.5%, 53.0%, 62.1%, and 78.8% ( Conclusion: RAR showed higher discriminatory performance than RDW or albumin alone in AMI-CS patients and may be considered a candidate prognostic marker requiring further validation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.